AI and imaging advances revolutionize multiple sclerosis diagnosis

FHS
July 22, 2024
12:47 am

A study in Translational Vision Science & Technology reveals that integrating AI with IR-SLO and OCT imaging improves the automated diagnosis and classification of multiple sclerosis.

Hutchmed’s licensing deal, worth up to $227M; Tyra’s $200 PIPE

Plus, news about Anbogen Therapeutics and Vera Therapeutics: Hutchmed inks deal of up to $227.5M: The company is licensing two drugs to Immagene Biopharmaceuticals: IMG-007,

February 3, 2024

Long-term high fluoride exposure during adolescence causes hippocampal impairments

Researchers evaluated the impacts of prolonged fluoride exposure during adolescence and adulthood on cognition and associated hippocampal alterations.

July 13, 2023

Few Teens Regret Gender-Affirming Medical Care, Survey Shows

Most adolescents who started gender-affirming medical care didn’t regret it, according to survey responses from participants in the Trans Youth Project. Out of 220 youths,

October 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.